Role of Exchange Transfusion in Pediatric Sickle Cell Disease
Exchange transfusion is indicated for acute life-threatening complications of sickle cell disease including acute chest syndrome, stroke, and splenic sequestration, with automated red cell exchange being preferred over simple transfusion for severe presentations. 1
Indications for Exchange Transfusion
Acute Indications
Acute Chest Syndrome (ACS)
Stroke Management
- For acute cerebral infarction: Exchange transfusion designed to reduce sickle hemoglobin to <30% of total hemoglobin 2
- Initial management includes evaluation by a multidisciplinary team and prompt neuroimaging 3
- For patients with suspected stroke: Simple transfusion followed immediately by exchange transfusion (or direct exchange transfusion) if hemoglobin is >4 g/dL and <10 g/dL 3
Splenic Sequestration
- Characterized by rapidly enlarging spleen and decrease in hemoglobin >2 g/dL below baseline 2
- Careful administration of red blood cell transfusions may be lifesaving 2
- Caution needed to avoid acute overtransfusion to hemoglobin >10 g/dL, as sequestered red cells may be released as the event resolves 2
Preventive Indications
Stroke Prevention
Pre-operative Management
Methods of Exchange Transfusion
Automated Red Cell Exchange (RCE)
Manual Exchange Transfusion
Isovolemic Hemodilution RCE (IHD-RCE)
Target Parameters and Monitoring
Target Values
Monitoring Requirements
Complications and Management
Iron Overload
Alloimmunization
Other Complications
Special Considerations
Resource-Limited Settings
Multidisciplinary Approach
Exchange transfusion represents a critical intervention in the management of pediatric sickle cell disease, particularly for acute, life-threatening complications. The choice between automated and manual exchange should be based on availability of resources, patient characteristics, and the urgency of reducing HbS levels.